Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Change in Cash (2016 - 2025)

Historic Change in Cash for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to -$17.3 million.

  • Phibro Animal Health's Change in Cash fell 21342.78% to -$17.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$11.6 million, marking a year-over-year decrease of 13397.84%. This contributed to the annual value of -$2.6 million for FY2025, which is 10877.54% down from last year.
  • As of Q4 2025, Phibro Animal Health's Change in Cash stood at -$17.3 million, which was down 21342.78% from $4.7 million recorded in Q3 2025.
  • Phibro Animal Health's 5-year Change in Cash high stood at $22.2 million for Q4 2021, and its period low was -$31.2 million during Q1 2023.
  • Its 5-year average for Change in Cash is $1.0 million, with a median of $2.8 million in 2022.
  • In the last 5 years, Phibro Animal Health's Change in Cash surged by 246496.48% in 2021 and then crashed by 110299.15% in 2024.
  • Over the past 5 years, Phibro Animal Health's Change in Cash (Quarter) stood at $22.2 million in 2021, then plummeted by 135.38% to -$7.9 million in 2022, then decreased by 29.59% to -$10.2 million in 2023, then soared by 249.63% to $15.2 million in 2024, then plummeted by 213.43% to -$17.3 million in 2025.
  • Its Change in Cash stands at -$17.3 million for Q4 2025, versus $4.7 million for Q3 2025 and $7.7 million for Q2 2025.